SciELO - Scientific Electronic Library Online

SciELO - Scientific Electronic Library Online

Article References

KUZNIK, Andreas et al. Evaluating the cost-effectiveness of combination antiretroviral therapy for the prevention of mother-to-child transmission of HIV in Uganda. Bull World Health Organ [online]. 2012, vol.90, n.8, pp. 595-603. ISSN 0042-9686.  http://dx.doi.org/10.2471/BLT.11.095430.

    1. The world fact book. Africa: Uganda. Langley: Central Intelligence Agency;. 2011. Available from: https://www.cia.gov/library/publications/the-world-factbook/geos/ug.html [accessed 21 May 2012] [ Links ]

    2. Global report: UNAIDS report on the global AIDS epidemic 2010. Geneva: United Nations Joint Programme on HIV/AIDS; 2010. Available from: http://www.unaids.org/globalreport/global_report.htm [accessed 21 May 2012] [ Links ]

    3. PMTCT strategic vision 2010–2015: preventing mother-to-child transmission of HIV to reach the UNGASS and Millennium Development Goals. Geneva: World Health Organization; 2010. Available from: www.who.int/hiv/pub/mtct/strategic_vision.pdf [accessed 21 May 2012] [ Links ]

    4. UNGASS country progress report Uganda: January 2008–December 2009. Kampala: Government of Uganda; 2010. [ Links ]

    5. United Nations Special Session on HIV/AIDS. Implementing the declaration of commitment on HIV/AIDS: action guide for the United Nations country teams. New York: United Nations General Assembly; 2001. [ Links ]

    6. Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach. Geneva: World Health Organization; 2010. [ Links ]

    7. The integrated national guidelines on antiretroviral therapy, prevention of mother to child transmission of HIV and infant & young child feeding. Kampala: STD/AIDS Control Programme, Ministry of Health; 2011. [ Links ]

    8. Babigumira JB, Castelnuovo B, Stergachis A, Kiragga A, Shaefer P, Lamorde M et al. Cost effectiveness of a pharmacy-only refill program in a large urban HIV/AIDS clinic in Uganda. PLoS ONE 2011;6:e18193. doi:10.1371/journal.pone.0018193 PMID:21464895 [ Links ]

    9. Shapiro RL, Hughes MD, Ogwu A, Kitch D, Lockman S, Moffat C et al. Antiretroviral regimens in pregnancy and breast-feeding in Botswana. N Engl J Med 2010;362:2282–94. doi:10.1056/NEJMoa0907736 PMID:20554983 [ Links ]

    10. Kuhn L, Aldrovandi GM, Sinkala M, Kankasa C, Semrau K, Mwiya M et al. Effects of early, abrupt weaning on HIV-free survival of children in Zambia. N Engl J Med 2008;359:130–41. doi:10.1056/NEJMoa073788 PMID:18525036 [ Links ]

    11. Shah M, Johns B, Abimiku A, Walker DG. Cost-effectiveness of new WHO recommendations for prevention of mother-to-child transmission of HIV in a resource-limited setting. AIDS 2011;25:1093–102. doi:10.1097/QAD.0b013e32834670b9 PMID:21505317 [ Links ]

    12. Generic antiretroviral drug pricelist. Kampala: Medical Access Uganda; 2011. [ Links ]

    13. Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants: towards universal access. Recommendations for a public health approach (2010 version). Geneva: World Health Organization; 2010. [ Links ]

    14. Uganda Demographic and Health Survey. Calverton: ORC Macro; 2006. [ Links ]

    15. Nduati R, John G, Mbori-Ngacha D, Richardson B, Overbaugh J, Mwatha A et al. Effect of breastfeeding and formula feeding on transmission of HIV-1: a randomized clinical trial. JAMA 2000;283:1167–74. doi:10.1001/jama.283.9.1167 PMID:10703779 [ Links ]

    16. Taha TE. Mother-to-child transmission of HIV-1 in sub-Saharan Africa: past, present and future challenges. Life Sci 2011;88:917–21. doi:10.1016/j.lfs.2010.09.031 PMID:20933522 [ Links ]

    17. Petra Study Team. Efficacy of three short-course regimens of zidovudine and lamivudine in preventing early and late transmission of HIV-1 from mother to child in Tanzania, South Africa, and Uganda (Petra study): a randomised, double-blind, placebo-controlled trial. Lancet 2002;359:1178–86. doi:10.1016/S0140-6736(02)08214-4 PMID:11955535 [ Links ]

    18. Becquet R, Ekouevi DK, Arrive E, Stringer JS, Meda N, Chaix ML et al. Universal antiretroviral therapy for pregnant and breast-feeding HIV-1-infected women: towards the elimination of mother-to-child transmission of HIV-1 in resource-limited settings. Clin Infect Dis 2009;49:1936–45. doi:10.1086/648446 PMID:19916796 [ Links ]

    19. Hladik W, Stover J, Esiru G, Harper M, Tappero J. The contribution of family planning towards the prevention of vertical HIV transmission in Uganda. PLoS ONE 2009;4:e7691. doi:10.1371/journal.pone.0007691 PMID:19888347 [ Links ]

    20. Newell ML, Coovadia H, Cortina-Borja M, Rollins N, Gaillard P, Dabis F. Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis. Lancet 2004;364:1236–43. doi:10.1016/S0140-6736(04)17140-7 PMID:15464184 [ Links ]

    21. Johansson KA, Robberstad B, Norheim OF. Further benefits by early start of HIV treatment in low income countries: survival estimates of early versus deferred antiretroviral therapy. AIDS Res Ther 2010;7:3. doi:10.1186/1742-6405-7-3 PMID:20180966 [ Links ]

    22. Population Division of the Department of Economic and Social Affairs of the United Nations Secretariat. HIV/AIDS and fertility in sub-Saharan Africa: a review of the research literature. New York: United Nations; 2002. [ Links ]

    23. Murray C, Lopez A, editors. The global burden of disease. Cambridge: Harvard University Press; 1996. [ Links ]

    24. Edejer TT-T, Baltussen R, Adam T, Hutubessy R, Acharya A, Evans D, et al., editors. Making choices in health: WHO guide to cost-effectiveness analysis. Geneva: World Health Organization; 2003. [ Links ]

    25. Nachega JB, Hislop M, Dowdy DW, Chaisson RE, Regensberg L, Maartens G. Adherence to nonnucleoside reverse transcriptase inhibitor-based HIV therapy and virologic outcomes. Ann Intern Med 2007;146:564–73. PMID:17438315 [ Links ]

    26. Guay LA, Musoke P, Fleming T, Bagenda D, Allen M, Nakabiito C et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet 1999;354:795–802. PMID:10485720 [ Links ]

    27. The World Bank Data Development Group. World development indicators. Washington: The World Bank; 2011. [ Links ]

    28. World Health Organization [Internet]. Cost-effectiveness thresholds. Geneva: World Health Organization; 2011. Available from: http://www.who.int/choice/costs/CER_thresholds/en/index.html [accessed 21 May 2012] [ Links ]

    29. Orlando S, Marazzi M, Mancinelli S, Liotta G, Ceffa S, Giglio P et al. Cost-effectiveness of using HAART in prevention of mother-to-child transmission in the DREAM-Project Malawi. J Acquir Immune Defic Syndr 2010;55:631–4. doi:10.1097/QAI.0b013e3181f9f9f5 PMID:21934555 [ Links ]

    30. Coutsoudis A, Dabis F, Fawzi W, Gaillard P, Haverkamp G, Harris DR et al.; Breastfeeding and HIV International Transmission Study Group. Late postnatal transmission of HIV-1 in breast-fed children: an individual patient data meta-analysis. J Infect Dis 2004;189:2154–66. doi:10.1086/420834 PMID:15181561 [ Links ]

    31. Towards universal access: scaling up priority HIV/AIDS interventions in the health sector: progress report 2010. Geneva: World Health Organization; 2010. [ Links ]

    32. Sanne I, Orrell C, Fox MP, Conradie F, Ive P, Zeinecker J et al. Nurse versus doctor management of HIV-infected patients receiving antiretroviral therapy (CIPRA-SA): a randomised non-inferiority trial. Lancet 2010;376:33–40. doi:10.1016/S0140-6736(10)60894-X PMID:20557927 [ Links ]

    33. Nash D, Katyal M, Brinkhof MW, Keiser O, May M, Hughes R et al. Long-term immunologic response to antiretroviral therapy in low-income countries: a collaborative analysis of prospective studies. AIDS 2008;22:2291–302. doi:10.1097/QAD.0b013e3283121ca9 PMID:18981768 [ Links ]

    34. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011;365:493–505. doi:10.1056/NEJMoa1105243 PMID:21767103 [ Links ]

    35. Quinn TC, Wawer MJ, Sewankambo N, Serwadda D, Li C, Wabwire-Mangen F et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med 2000;342:921–9. doi:10.1056/NEJM200003303421303 PMID:10738050 [ Links ]

    36. Donnell D, Baeten JM, Kiarie J, Thomas KK, Stevens W, Cohen CR et al. Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis. Lancet 2010;375:2092–8. doi:10.1016/S0140-6736(10)60705-2 PMID:20537376 [ Links ]